WHO GRADE II GLIOMA
Clinical trials for WHO GRADE II GLIOMA explained in plain language.
Never miss a new study
Get alerted when new WHO GRADE II GLIOMA trials appear
Sign up with your email to follow new studies for WHO GRADE II GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise for untreated brain tumor patients
Disease control OngoingThis study tests a new drug called DS-1001b in 25 people with a specific type of slow-growing brain tumor (grade II glioma) that has an IDH1 mutation. Participants have not had chemotherapy or radiation before. The goal is to see if the drug can shrink or control the tumor and to…
Matched conditions: WHO GRADE II GLIOMA
Phase: PHASE2 • Sponsor: Daiichi Sankyo Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New hope for young brain tumor patients: drug combo targets IDH mutations
Disease control OngoingThis early-phase study tests a new drug (BGB-290) combined with chemotherapy (temozolomide) in teens and young adults with a type of brain tumor called glioma that has an IDH mutation. The goal is to find the safest dose and see how well the combination works for both newly diagn…
Matched conditions: WHO GRADE II GLIOMA
Phase: PHASE1 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New radiation method aims to protect scalp in brain tumor patients
Disease control OngoingThis study tests a precise type of radiation therapy (IM-SRT) for people with newly diagnosed grade II to IV gliomas. The goal is to deliver a high dose of radiation directly to the tumor while minimizing damage to the scalp, which may reduce wound infections and the need for met…
Matched conditions: WHO GRADE II GLIOMA
Phase: NA • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC